-
Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018
-
View Affiliations Hide AffiliationsLore Merdrignacl.merdrignac epiconcept.fr
-
View Collaborators
PERTINENT group: Lore Merdrignac, Camelia Savulescu, Marta Valenciano, Alain Moren, Pavla Křížová, Kateřina Fabiánová, Jana Zavadilová, Zuzana Blechová, Květa Bláhová, Pavel Kosina, Josef Sýkora, Alena Holčíková, Petr Širůček, Daniel Lévy-Brühl, Fatima Aït El Belghiti, Adèle Grembombo, Sophie Guillot, Sylvain Brisse, Julie Toubiana, Suzanne Cotter, Jane Murphy, Robert Cunney, Norma O’Shaughnessy, Adele Habington, Niamh O’Sullivan, Elisabetta Pandolfi, Alberto E Tozzi, Caterina Rizzo, Luisa Russo, Ilaria Campagna, Francesco Gesualdo, Sara Ciampini, Valentina Annarosa Ferro, Elena Boccuzzi, Elmira Flem, Håkon Bøås, Terese Bekkevold, Liliana Vazquez Fernandez, Carmen Muñoz-Almagro, Cristina Esteva, Miguel Lanaspa Perez, Mireia Jané, Gloria Carmona, Lesly Acosta, Yolanda Jordan Garcia, Manuel García Cenoz, Ana Navascués, Leticia Fernandino Zubieta, Jesús Castilla, Thomas Hanslik, Sabrina Bacci, Gianfranco SpiteriView Citation Hide Citation
Citation style for this article: . Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018. Euro Surveill. 2021;26(4):pii=1900762. https://doi.org/10.2807/1560-7917.ES.2021.26.4.1900762 Received: 19 Dec 2019; Accepted: 17 Aug 2020
- Previous Article
- Table of Contents
- Next Article
Abstract
PERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites).
This observational study aimed to estimate annual pertussis incidence per site from 2016 to 2018 and respective trends between 2017 and 2018. Pertussis cases were described, including their severity.
We developed a generic protocol and laboratory guidelines to harmonise practices across sites. Cases were hospitalised infants testing positive for Bordetella pertussis by PCR or culture. Sites collected demographic, clinical, laboratory data, vaccination status, and risk/protective factors. We estimated sites’ annual incidences by dividing case numbers by the catchment populations.
From December 2015 to December 2018, we identified 469 cases (247 males; 53%). The median age, birthweight and gestational age were 2.5 months (range: 0–11.6; interquartile range (IQR): 2.5), 3,280 g (range: 700–4,925; IQR: 720) and 39 weeks (range: 25–42; IQR: 2), respectively. Thirty cases (6%) had atypical presentation either with cough or cyanosis only or with absence of pertussis-like symptoms. Of 330 cases with information, 83 (25%) were admitted to intensive care units including five deceased infants too young to be vaccinated. Incidence rate ratios between 2018 and 2017 were 1.43 in Czech Republic (p = 0.468), 0.25 in Catalonia (p = 0.002), 0.71 in France (p = 0.034), 0.14 in Ireland (p = 0.002), 0.63 in Italy (p = 0.053), 0.21 in Navarra (p = 0.148) and zero in Norway.
Incidence appeared to decrease between 2017 and 2018 in all but one site. Enhanced surveillance of hospitalised pertussis in Europe is essential to monitor pertussis epidemiology and disease burden.
Full text loading...